Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052558 · ClinicalTrials.gov registry record · Phase 3
GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma
A Phase 3 study, sponsored by Glaukos Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 164
- Enrollment target
NCT01052558 is a Phase 3 study that has completed, run by Glaukos Corporation. The registered enrollment target is 164 participants.
The verdict
NCT01052558, a Phase 3 study, has completed, sponsored by Glaukos Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 164 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the GTS400 trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hypertension and co-existing cataract.
Interventions
- PROCEDURE Cataract Surgery
- DEVICE iStent Inject (GTS400)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2010-01 |
| Est. Completion | 2013-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01052558
The ClinicalTrials.gov registry entry for NCT01052558 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cataract Surgery is the first listed.
NCT01052558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01052558 about?
NCT01052558 is a clinical study titled "GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma". The purpose of this study is to evaluate the safety and efficacy of the GTS400 trabecular micro-bypass stent in reducing intraocular pressure (IOP) in subjects with open-angle glaucoma or ocular hypertension and co-existing cataract.
What is the current status of trial NCT01052558?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 164 participants. The study started on 2010-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01052558?
The interventions under investigation include: Cataract Surgery (PROCEDURE), iStent Inject (GTS400) (DEVICE).
Who is sponsoring clinical trial NCT01052558?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.